Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma

With a rapidly developing immunotherapeutic landscape for patients with metastatic clear cell renal cell carcinoma, biomarkers of efficacy are highly desirable to guide treatment strategy. Hematoxylin and eosin (H&E)-stained slides are inexpensive and widely available in pathology laboratories,...

Descripción completa

Detalles Bibliográficos
Autores principales: Deutsch, Julie Stein, Lipson, Evan J., Danilova, Ludmila, Topalian, Suzanne L., Jedrych, Jaroslaw, Baraban, Ezra, Ged, Yasser, Singla, Nirmish, Choueiri, Toni K., Gupta, Saurabh, Motzer, Robert J., McDermott, David, Signoretti, Sabina, Atkins, Michael, Taube, Janis M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975323/
https://www.ncbi.nlm.nih.gov/pubmed/36812889
http://dx.doi.org/10.1016/j.xcrm.2023.100947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975323/
https://www.ncbi.nlm.nih.gov/pubmed/36812889
http://dx.doi.org/10.1016/j.xcrm.2023.100947

Ejemplares similares